Cysteine cathepsins play an important part in tumor progression,with the most evidence existing for cathepsin B. Therefore, theseenzymes represent highly promising targets for the development ofradiolabeled activity-based probes, which would allow for their quantitativedetection at the cellular level and potentially also for imaging in vivo by PET and SPECT. This evidence concerns the gene CTSB and neoplasm.